EXHIBIT 3.1 UNDERWRITING AGREEMENT 2,610,000 COMMON SHARES ID BIOMEDICAL CORPORATIONUnderwriting Agreement • May 22nd, 2003 • Id Biomedical Corp • Biological products, (no disgnostic substances) • New York
DRAFT UNDERWRITING AGREEMENT ---------------------- 5,000,000 COMMON SHARES ID BIOMEDICAL CORPORATIONUnderwriting Agreement • October 1st, 2003 • Id Biomedical Corp • Biological products, (no disgnostic substances) • New York
COMBINATION AGREEMENT AMONG GLAXOSMITHKLINE plc, GLAXOSMITHKLINE INC., AND ID BIOMEDICAL CORPORATION AS OF SEPTEMBER 7, 2005Combination Agreement • September 13th, 2005 • Id Biomedical Corp • Biological products, (no disgnostic substances) • British Columbia
THIS COMBINATION AGREEMENT dated as of September 7, 2005, is entered into by and among GlaxoSmithKline plc, a public limited company organized under the laws of England and Wales (“Parent”) for purposes of its guarantee pursuant to subsection 5.2(d) hereof, GlaxoSmithKline Inc., a Canadian corporation (“GSK”), and ID Biomedical Corporation, a corporation existing under the laws of British Columbia (the “Company”).
CREDIT AGREEMENT BETWEEN AND GLAXOSMITHKLINE INC. MADE AS OF September 7, 2005 CREDIT AGREEMENTCredit Agreement • September 13th, 2005 • Id Biomedical Corp • Biological products, (no disgnostic substances) • British Columbia
